Biosearch reacquires Ramoplanin

Biosearch Italia (NMerc:BIO) will reacquire from partner IntraBiotics (IBPI) North American development and marketing rights to its Ramoplanin inhibitor of Gram-positive bacterial cell wall synthesis ...